Astellas

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Flag link:
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Flag link:
Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series
Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series
Drugs.com
Astellas
zolbetuximab
clinical trials
gastric cancer
Flag link:
US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi
US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi
Fierce Pharma
Pfizer
Astellas
Xtandi
prostate cancer
drug pricing
NIH
march-in rights
Flag link:
Pfizer and Astellas report positive data from prostate cancer therapy trial
Pfizer and Astellas report positive data from prostate cancer therapy trial
Clinical Trials Arena
Pfizer
Astellas
prostate cancer
clinical trials
Enzalutamide
leuprolide
Flag link:
Astellas Xospata comes up short again in bid to expand leukemia use
Astellas Xospata comes up short again in bid to expand leukemia use
Fierce Pharma
Astellas
Xospata
AML
clinical trials
Flag link:
Astellas Presents Update on Recently Cleared Pompe Gene Therapy Trial
Astellas Presents Update on Recently Cleared Pompe Gene Therapy Trial
BioSpace
Astellas
Pompe disease
clinical trials
AT845
Flag link:
Astellas has menopause accelerated approval ambition thwarted by FDA at last minute
Astellas has menopause accelerated approval ambition thwarted by FDA at last minute
Fierce Biotech
Astellas
menopause
fezolinetant
FDA
Flag link:
ASCO GU: Pfizer touts Talzenna's strong showing in PARP prostate cancer battle with AstraZeneca, J&J
ASCO GU: Pfizer touts Talzenna's strong showing in PARP prostate cancer battle with AstraZeneca, J&J
Fierce Pharma
ASCO GU
Pfizer
Astellas
Xtandi
prostate cancer
Flag link:
Astellas buys Super Bowl commercial spot to raise menopause awareness
Astellas buys Super Bowl commercial spot to raise menopause awareness
Medical Marketing and Media
Astellas
menopause
Super Bowl
DTC advertising
television ads
fezolinetant
Flag link:
Astellas Taps New CEO in Nod to Accelerated Growth
Astellas Taps New CEO in Nod to Accelerated Growth
BioSpace
Astellas
Pharma CEOs
Naoki Okamura
Flag link:
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Endpoints
Sandoz
Novartis
Astellas
antifungals
Mycamine
generics
Flag link:
Astellas, after years of gene therapy woes, gets rare boost with FDA lifting of Pompe clinical hold
Astellas, after years of gene therapy woes, gets rare boost with FDA lifting of Pompe clinical hold
Fierce Biotech
Astellas
Pompe disease
gene therapy
AT845
Flag link:
ASCO-GI 2023 – zolbetuximab opens up a stomach cancer niche
ASCO-GI 2023 – zolbetuximab opens up a stomach cancer niche
EP Vantage
ASCO-GI
zolbetuximab
cancer of the gastro-esophageal junction
Astellas
Flag link:
Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug
Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug
Stat
cancer
oncology
Joe Biden
Astellas
Xtandi
prostate cancer
Flag link:
Astellas loses bid to block Lexiscan generics in US
Astellas loses bid to block Lexiscan generics in US
Pharmaphorum
legal
Astellas
Pfizer
Lexiscan
patents
Flag link:
Astellas’ Phase III gastric cancer therapy trial meets primary endpoint
Astellas’ Phase III gastric cancer therapy trial meets primary endpoint
Clinical Trials Arena
Astellas
clinical trials
zolbetuximab
gastric cancer
Flag link:
Astellas' $1.3B antibody strikes first in hot cancer field, extending survival in phase 3
Astellas' $1.3B antibody strikes first in hot cancer field, extending survival in phase 3
Fierce Biotech
Astellas
zolbetuximab
clinical trials
cancer
gastric cancer
Flag link:
What causes hot flashes? Astellas ramps up educational campaign ahead of FDA decision
What causes hot flashes? Astellas ramps up educational campaign ahead of FDA decision
Endpoints
Astellas
hot flashes
menopause
fezolinetant
patient education
Flag link:
String of gene therapy deals spurs cautious optimism on Wall Street
String of gene therapy deals spurs cautious optimism on Wall Street
BioPharma Dive
gene therapy
M&A
Akouos
AGTC
Taysha Gene Therapies
Astellas
Eli Lilly
Syncona
Flag link:

Pages